DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is ...
What Happened? A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as ...
This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system.